Entrepreneurial treatment activism for undone science: mannitol and Parkinson’s disease

This paper describes CliniCrowd, a patient-designed, entrepreneurial, crowd-sourced citizen-science approach to evaluating mannitol—essentially, an orphan drug—as a Parkinson’s disease treatment. As such, CliniCrowd addresses ‘undone science’, and our paper contributes to the sociological literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzmen-Carmeli, Shlomo, Rier, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Palgrave Macmillan UK 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536910/
https://www.ncbi.nlm.nih.gov/pubmed/34721649
http://dx.doi.org/10.1057/s41292-021-00258-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536910/
https://www.ncbi.nlm.nih.gov/pubmed/34721649
http://dx.doi.org/10.1057/s41292-021-00258-0

Ejemplares similares